Punjab Chemicals Q1 FY27 Earnings Analysis

Published 5 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹1.3K Cr

Price

1,100.1

Market Cap

₹1.3K Cr

P/E Ratio

20.1

Revenue Rank

Rank 3

Margin Rank

Rank 2

Earnings Summary

- Company maintains guidance of 15%-20% year-on-year revenue growth for FY '27 and beyond, confident of hitting the upper end of this range. - Revenue growth guidance maintained at 15%-20% year-on-year, with confidence to achieve upper range in FY '27.

📊 Revenue & Sales Performance

Rank 3

- Company maintains guidance of 15%-20% year-on-year revenue growth for FY '27 and beyond, confident of hitting the upper end of this range. - New products expected to grow volumes by about 25% in FY '27, contributing significantly to incremental revenues. - Existing product volumes projected to remain steady, with incremental price improvements anticipated. - Overall volume growth in FY '26 was around 14%, primarily driven by new products. - By FY '28, company expects revenues from current facilities to reach approximately INR 1400-1500 crores due to new products and existing product growth. - CDMO business to contribute between INR 150-200 crores in the next 2 years, supporting overall revenue growth. - Long-term focus on adding new products, improving product mix, and expanding customer base, particularly in European and Japanese markets, to sustain growth.

📈 Profitability & Margins

Rank 2

- Revenue growth guidance maintained at 15%-20% year-on-year, with confidence to achieve upper range in FY '27. - New product contribution growing strongly; expected 25% volume growth in new products next year, aiding incremental revenue. - Gross margins hovering around 40%, expected to improve by approximately 100 bps annually over next couple of years due to new product mix. - EBITDA margin expected to improve gradually from around 12% to 15% over next 2-3 years with stable business and cost efficiencies. - PAT for FY '26 grew 64.3% YoY; with continued focus on operational efficiencies and product mix optimization, profitability is expected to strengthen. - CDMO business targeted to reach EBITDA margins of 17%-18% after three years through R&D and efficiency gains. - Overall, management expects stable to improving earnings driven by volume growth, new product launches, pricing actions, and operational improvements.

🏗️ Capital Expenditure Plans

Yes

- For FY '27, total planned CAPEX is between INR 105 crores to INR 130 crores, broken down as: - Maintenance/asset renewal CAPEX: INR 25 crores to INR 30 crores - Capacity de-bottlenecking, compliance, or product mix changes: INR 20 crores - New production block: INR 60 crores to INR 80 crores - Additional potential CAPEX on a greenfield project expected beyond current planned spend; land acquisition targeted by Q2 or Q3 FY '27. - Existing Lalru plant has capacity for two more blocks with CAPEX estimated between INR 80 crores to INR 100 crores. - Emphasis on investment aligned with expanding global opportunities and Make in India initiative. - Past 2-3 years have seen around INR 35-40 crores in capacity addition or compliance-related CAPEX and INR 25-30 crores on asset renewal annually. - Acquisition remains a possibility; options are being explored but previous attempts were hindered by legal due diligence issues.

💰 Fundraising & Capital Structure

No information

- There is no indication of any immediate plans for new fundraising through debt or equity. - The management stated that the company's debt-equity ratio is currently good with no intention to increase debt. - Any future debt movements will be communicated to stakeholders as and when they occur. - CAPEX plans for FY '27 and beyond are to be funded through internal accruals and ongoing investments without raising new debt. - The company continues to focus on maintaining financial discipline within a dynamic operating environment.

📋 Order Book & Pipeline

Yes

- The company has shifted some herbicide-heavy product orders from Q4 to Q1, building inventory in Jan-March to capture the April-October demand cycle. - This inventory buildup primarily involves existing products; all new products produced are sold immediately. - The incremental business expected from this inventory buildup is about 5%-7% on existing products. - The company prefers producing against firm demand, not speculative stocking. - Inventory levels, currently around 150 days, are expected to normalize by end of Q1 as most inventory is being liquidated by May-June. - There is no specific quantification of the deferred or pending orders shared by management. - The orderbook remains steady with no cancellations or deferments, despite higher costs, indicating good demand visibility.

Key Metrics

Revenue

Rank 3

Margin

Rank 2

Capex

Yes

Fundraise

No information

Order Book

Yes

Frequently Asked Questions

What were Punjab Chemicals Q1 FY27 results?

- Company maintains guidance of 15%-20% year-on-year revenue growth for FY '27 and beyond, confident of hitting the upper end of this range. - Revenue growth guidance maintained at 15%-20% year-on-year, with confidence to achieve upper range in FY '27.

What is Punjab Chemicals share price analysis?

Punjab Chemicals currently shows a below-average growth signal. The stock trades at a P/E of 20.1 with a market cap of ₹1,345. Investors should review the full earnings analysis for detailed insights.

Is Punjab Chemicals planning capital expenditure?

- For FY '27, total planned CAPEX is between INR 105 crores to INR 130 crores, broken down as: - Maintenance/asset renewal CAPEX: INR 25 crores to INR 30 crores - Capacity de-bottlenecking, compliance, or product mix changes: INR 20 crores - New production block: INR 60 crores to INR 80 crores - Additional potential CAPEX on a greenfield project expected beyond current planned spend; land acquisition targeted by Q2 or Q3 FY '27.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Fertilizers & Agrochemicals this season

  • Krishana Phoschem Ltd (Q1 FY27)

    Krishana Phosch. Q1 FY27 quarterly results analysis. - FY27 revenue growth expected at 35%-40%, driven by capacity utilization and imports. Market Cap ₹5,526, P

  • GSP Crop Science Ltd (Q1 FY27)

    GSP Crop Science Ltd Q1 FY27 quarterly results analysis. - GSP Crop Science targets a 5%-7% higher growth rate in revenue over the next 3 years, building on pas

  • Madhya Bharat Agro Products Ltd (Q1 FY27)

    Madhya Bharat Agro Products Ltd Q1 FY27 quarterly results analysis. - Phase-I Dhule facility partially commissioned; full Phase-I capacity expected by October 2

  • Sharda Cropchem Ltd (Q1 FY27)

    Sharda Cropchem Ltd Q1 FY27 quarterly results analysis. - Revenue growth guidance for FY27 is expected to be 10% to 15%, with potential to go higher or lower ba